Clinical Trial Update: Study of DA-9801 to Treat Diabetic Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DA-9801 in diabetic neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathies

Drugs mentioned

• DA-9801

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Diabetic Neuropathies | Phase 2 | Status: COMPLETED